Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting

Overview of attention for article published in Reumatologia Clinica, December 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#29 of 264)
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 7,448 followers.

#PublicaSalutIB Eficàcia i seguretat del tocilizumab en monoteràpia en pacients amb artritis reumatoide naïf i no naïf a biològics en un entorn del món real https://t.co/oeE8GoGQMG @asef_ibsalut https://t.co/sZRpVdQT8a https://t.co/3rvhlgwf7V

#PublicaSalutIB Eficàcia i seguretat del tocilizumab en monoteràpia en pacients amb artritis reumatoide naïf i no naïf a biològics en un entorn del món real https://t.co/1ZyKz1mmlX @asef_ibsalut https://t.co/l9f2453zAU https://t.co/K3DRqRr0hi

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.